Dr. Hasserjian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Wrn 225
Boston, MA 02114Phone+1 617-724-1445Fax+1 617-726-7474
Education & Training
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1990 - 1995- Brigham and Women's HospitalFellowship, Hematopathology, 1992 - 1993
Harvard Medical SchoolClass of 1990
Certifications & Licensure
MA State Medical License 1994 - 2025
NH State Medical License 2015 - 2025- American Board of Pathology Anatomic Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- Impact of myelodysplasia-related mutations on 2022 European LeukemiaNet genetic risk classification in de novo acute myeloid leukemia with normal karyotype.Srija Shanker, Robert P Hasserjian, Yazan Madanat, Olga K Weinberg, Miguel D Cantu
American Journal of Hematology. 2025-01-01 - Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology.Matteo G Della Porta, Jan Philipp Bewersdorf, Yu-Hung Wang, Robert P Hasserjian
Histopathology. 2025-01-01 - Haematological setpoints are a stable and patient-specific deep phenotype.Brody H Foy, Rachel Petherbridge, Maxwell T Roth, Cindy Zhang, Daniel C De Souza
Nature. 2024-12-11
Journal Articles
- Hematopoietic Neoplasms with 9p24/JAK2 Rearrangement: A Multicenter StudyGuilin Tang, Daniel A Arber, Elizabeth M Margolskee, Heesun J Rogers, Robert P Hasserjian, Eric D Hsi, Sa A Wang, Wayne Tam, Adam Bagg, Olga Weinberg, Jonathan I Lake,..., Nature
Abstracts/Posters
- TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic SyndromesRobert P. Hasserjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Bone Marrow Morphologic Findings in Patients Receiving IDH Inhibitor Therapy in Combination with Intensive Induction Chemotherapy: Challenges with Interpretation of th...Robert P. Hasserjian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Diagnostic Algorithm for Lower-Risk Myelodysplastic SyndromesRobert Hasserjian, MD, Nature, Orlando, FL, 12/8/2019
Lectures
- Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Mye...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Clinical, Immunophenotypic and Genomic Findings  of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow P...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Surgical Pathology for the Practicing PathologistHarvard Medical School, Scottsdale, Arizona - 1/14/2012
Press Mentions
Newly Characterized Mutation May Define a Novel Leukemia Subtype in KidsFebruary 24th, 2022- Newly Characterized Mutation May Define Novel Pediatric AML SubtypeFebruary 17th, 2022
- Case 7-2019: A 73-Year-Old Woman with Swelling of the Right Groin and FeverFebruary 28th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
